News Releases

Date	Title
09/25/18	MiMedx Publishes Positive Results From Clinical Study Of Human Umbilical Cord For Diabetic Foot Ulcers
09/20/18	MiMedx Announces Nasdaq Listing Extension
09/20/18	Mimedx Provides Update on Previously Announced Senior Executive Separations
08/24/18	MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix®
08/15/18	MiMedx Receives Additional Nasdaq Listing Notice Due to Late Form 10-Q
08/15/18	MiMedx Provides Additional Information and Context to Wall Street Journal Article
08/13/18	MiMedx announces Nasdaq listing extension and Hearing Date
08/09/18	MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
08/02/18	MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International
07/26/18	MiMedx Announces Receipt of Nasdaq Letter